Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cipher Mining Inc (CIFR) vs Cassava Sciences Inc (FLNA) Price & Performance

Cipher Mining IncTrade
Cassava Sciences IncTrade

Price performance (Past 24H)

Key statistics

Cipher Mining Inc vs Cassava Sciences Inc — how do they compare? Cipher Mining Inc trades at $18.91 (market cap $8.13B), while Cassava Sciences Inc trades at $1.12 (market cap $52.66M). The key difference: Cipher Mining Inc is far larger — about 154.4× Cassava Sciences Inc's market cap, and Cipher Mining Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.

CIFRFLNA
Market Cap
$8.13B$52.66M
Sector
Basic MaterialsHealth
52-Week High
$29.18$4.64
52-Week Low
$4.72$1.09
Enterprise Value
$12.16B-$33.92M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cipher Mining Inc

CIFR trades at $20.085, down 9.16% over 24 hours, reflecting bearish technical signals despite unanimous analyst buy ratings. The company is transitioning from Bitcoin mining to AI data center operations, evidenced by a $11.4B contracted revenue backlog but faces significant financial strain with a -427.79% net income margin and negative cash flow from operations. Recent news highlights volatility driven by AI infrastructure developments and capital raises.

The outlook hinges on successful execution of its AI data center pivot, offering substantial upside to the $32.81 consensus price target, but high valuation multiples and persistent losses pose near-term risks. Investors must weigh transformative growth potential against cash burn and execution challenges in a competitive sector.

Cassava Sciences Inc

FLNA trades at $1.15, down 2.54% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company continues to report losses, with a net income of -$90.97M in 2025 and negative cash flow, though it has beaten EPS estimates for the last three quarters. Recent news highlights ongoing development in its TSC-related epilepsy therapies.

Despite consistent earnings beats, FLNA's negative profitability and cash burn pose significant risks. Analyst sentiment is positive with a 66.7% buy rating, but the stock's outlook depends heavily on clinical success and future funding. Investors should weigh the high-risk, high-reward nature of this biotech play.

Returns comparison

Trailing returns across standard periods

About Cipher Mining Inc

Cipher Mining is an industrial-scale technology company focused on Bitcoin mining infrastructure. It develops and operates data centers in the US designed to strengthen the Bitcoin network and support decentralized finance.

Read more on CIFR

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA